Search Results - Jeffrey Vietri
- Showing 1 - 5 results of 5
-
1
Uptake of 13-Valent Pneumococcal Conjugate Vaccine among US Adults Aged 19 to 64 Years with Immunocompromising Conditions by Jeffrey Vietri, James Harnett, Birol Emir, Erica Chilson
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece by George Gourzoulidis, Myrto Barmpouni, Vasiliki Kossyvaki, Jeffrey Vietri, Charalampos Tzanetakos
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Cost-utility of 20-valent pneumococcal conjugate vaccine compared to no vaccination and recommended alternative vaccines among Belgian adults by Sophie Marbaix, Annick Mignon, Audrey Taelman, Ahuva Averin, Mark Atwood, Jeffrey Vietri
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Cost-effectiveness analysis of adult pneumococcal conjugate vaccines for pneumococcal disease in Japan by Shigeki Nakamura, Masashi Mikami, Tomoyuki Hayamizu, Naohiro Yonemoto, Camille Moyon, Mark Gouldson, Catriona Crossan, Jeffrey Vietri, Kazumasa Kamei
Published 2024Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Cost-effectiveness of use of 20-valent pneumococcal conjugate vaccine among adults in Germany by Felicitas Kühne, Katharina Achtert, Franziska Püschner, Dominika Urbanski-Rini, Juliane Schiller, Ernestine Mahar, Josephine Friedrich, Mark Atwood, Ralf Sprenger, Jeffrey Vietri, Christof von Eiff, Christian Theilacker
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book